17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle.
Andrea MagriMatteo N BarbagliaChiara Z FogliaElisa BoccatoMichela E BurloneSarah ColePaola GiardaElena GrossiniArvind H PatelRosalba MinisiniMario PirisiPublished in: Liver international : official journal of the International Association for the Study of the Liver (2016)
17β-estradiol inhibits hepatitis C virus acting through its intracellular receptors, mainly interfering with late phases (assembly/release) of the hepatitis C virus life cycle.